Inactivation of the virulence factors from 2,3-butanediol-producing Klebsiella pneumoniae

Applied Microbiology and Biotechnology

Volumn 99, Issue 22, 2015, Pages 9427-9438

  Huynh, Duyen Thi Ngoc ^a   Kim, Ah Young ^a   Seol, In Hye ^a   Jung, Samuel ^a   Lim, Min Cheol ^a   Lee, Jeong A ^b   Jo, Mi Rae ^b   Choi, Soo Jin ^b   Kim, Borim ^c   Lee, Jinwon ^c   Kim, Wooki ^a   Kim, Young Rok ^a  

^a Kyung Hee University   (South Korea)

^b Seoul Women University   (South Korea)

^c Sogang University   (South Korea)

Author keywords

2,3 Butanediol; Capsule; Fimbriae; Klebsiella pneumoniae; Lipopolysaccharides; Virulence

Indexed keywords

CELLS;

2 ,3-BUTANEDIOL; CAPSULE; FIMBRIAE; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; VIRULENCE;

BACTERIA;

2,3 BUTANEDIOL; LIPOPOLYSACCHARIDE; VIRULENCE FACTOR; 2,3-BUTYLENE GLYCOL; BUTANEDIOL;

BACTERIUM; BIOTECHNOLOGY; CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; GROWTH RATE; INDUSTRIAL PRODUCTION; LIPID; PATHOGENICITY; POLYSACCHARIDE; RECOMBINATION; SUSTAINABILITY; VIRULENCE;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BATCH FERMENTATION; BIOMASS PRODUCTION; BLADDER EPITHELIUM; CELL ADHESION; CELL LINE; CONTROLLED STUDY; EPITHELIUM CELL; FIMBRIA; GENE INACTIVATION; GENE TARGETING; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; ILEUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MACROPHAGE; PHAGOCYTOSIS; BACTERIAL CAPSULE; BACTERIUM ADHERENCE; CHEMISTRY; FERMENTATION; GENETIC ENGINEERING; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; PROCEDURES; ULTRASTRUCTURE;

BACTERIA (MICROORGANISMS); KLEBSIELLA PNEUMONIAE;

BACTERIAL ADHESION; BACTERIAL CAPSULES; BUTYLENE GLYCOLS; CELL LINE; EPITHELIAL CELLS; FERMENTATION; FIMBRIAE, BACTERIAL; GENETIC ENGINEERING; HOMOLOGOUS RECOMBINATION; HUMANS; INDUSTRIAL MICROBIOLOGY; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; MACROPHAGES; MUTATION; VIRULENCE FACTORS;

EID: 84946471786     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-015-6861-1     Document Type: Article

References (49)

1. Afschar A, Rossell CV, Jonas R, Chanto AQ, Schaller K (1993) Microbial production and downstream processing of 2, 3-butanediol. J Biotechnol 27(3):317–329
2. Auwerx J (1991) The human leukemia cell line, THP-1: a multifacetted model for the study of monocyte-macrophage differentiation. Experientia 47(1):22–31
3. Blumenkrantz N, Asboe-Hansen G (1973) New method for quantitative determination of uronic acids. Anal Biochem 54:484–9
4. Celińska E, Grajek W (2009) Biotechnological production of 2, 3-butanediol—current state and prospects. Biotechnol Adv 27(6):715–725
5. Cryz S, Pitt T, Fürer E, Germanier R (1984) Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun 44:508–513
6. De Mas C, Jansen NB, Tsao GT (1988) Production of optically active 2, 3‐butanediol by Bacillus polymyxa. Biotechnol Bioeng 31(4):366–377
7. Di Martino P, Cafferini N, Joly B, Darfeuille-Michaud A (2003) Klebsiella pneumoniae type 3 pili facilitate adherence and biofilm formation on abiotic surfaces. Res Microbiol 154(1):9–16
8. Domenico P, Schwartz S, Cunha BA (1989) Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun 57(12):3778–3782
9. Fader RC, Duffy L, Davis CP, Kurosky A (1982) Purification and chemical characterization of type 1 pili isolated from Klebsiella pneumoniae. J Biol Chem 257(6):3301–3305
10. Favre-Bonté S, Licht TR, Forestier C, Krogfelt KA (1999) Klebsiella pneumoniae capsule expression is necessary for colonization of large intestines of streptomycin-treated mice. Infect Immun 67(11):6152–6156
11. Favre-Bonte S, Joly B, Forestier C (1999) Consequences of reduction of Klebsiella pneumoniae capsule expression on interactions of this bacterium with epithelial cells. Infect Immun 67(2):554–561
12. Firon N, Ofek I, Sharon N (1984) Carbohydrate-binding sites of the mannose-specific fimbrial lectins of Enterobacteria. Infect Immun 43(3):1088–1090
13. Fresno S, Jiménez N, Izquierdo L, Merino S, Corsaro MM, De Castro C, Parrilli M, Naldi T, Regué M, Tomás JM (2006) The ionic interaction of Klebsiella pneumoniae K2 capsule and core lipopolysaccharide. Microbiology 152(6):1807–1818
14. Gasser O, Hess C, Miot S, Deon C, Sanchez J-C (2003) Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res 285(2):243–257
15. Gerlach G-F, Clegg S, Allen BL (1989) Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol 171(3):1262–1270
16. Highsmith RC (1985) Floating and algal rafting as potential dispersal mechanisms in brooding invertebrates. Mar Ecol Prog Ser Oldendorf 25(2):169–179
17. Hornick D, Dayton C, Bedell G, Fick R (1988) Nontuberculous mycobacterial lung disease. Substantiation of a less aggressive approach. CHEST J 93(3):550–555
18. Jarvis WR, Munn VP, Highsmith AK, Culver DH, Hughes JM (1985) The epidemiology of nosocomial infections caused by Klebsiella pneumoniae. Infect Cont 6(02):68–74
19. Jung S-G, Jang J-H, Kim A-Y, Lim M-C, Kim B, Lee J, Kim Y-R (2013) Removal of pathogenic factors from 2, 3-butanediol-producing Klebsiella species by inactivating virulence-related wabg gene. Appl Microbiol Biotechnol 97(5):1997–2007
20. Kabha K, Nissimov L, Athamna A, Keisari Y, Parolis H, Parolis L, Grue RM, Schlepper-Schafer J, Ezekowitz A, Ohman DE (1995) Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect Immun 63(3):847–852
21. Lee H, Maddox I (1986) Continuous production of 2, 3-butanediol from whey permeate using Klebsiella pneumoniae immobilized in calcium alginate. Enz Microbial Technol 8(7):409–411
22. Link AJ, Phillips D, Church GM (1997) Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization. J Bacteriol 179(20):6228–6237
23. Maayan MC, Ofek I, Medalia O, Aronson M (1985) Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice. Infect Immun 49(3):785–789
24. Matatov R, Goldhar J, Skutelsky E, Sechter I, Perry R, Podschun R, Sahly H, Thankavel K, Abraham SN, Ofek I (1999) Inability of encapsulated Klebsiella pneumoniae to assemble functional type 1 fimbriae on their surface. FEMS Microbiol Lett 179(1):123–130
25. Nan H, Seo S-O, Oh EJ, Seo J-H, Cate JH, Jin Y-S (2014) 2, 3-Butanediol production from cellobiose by engineered Saccharomyces cerevisiae. Appl Microbiol Biotechnol 98(12):5757–5764
26. Nelson AL, Roche AM, Gould JM, Chim K, Ratner AJ, Weiser JN (2007) Capsule enhances pneumococcal colonization by limiting mucus-mediated clearance. Infect Immun 75(1):83–90
27. Ng CY, M-y J, Lee J, Oh M-K (2012) Production of 2, 3-butanediol in Saccharomyces cerevisiae by in silico aided metabolic engineering. Microbial Cell Fact 11:68
28. Perego P, Converti A, Del Borghi A, Canepa P (2000) 2,3-Butanediol production by Enterobacter aerogenes: selection of the optimal conditions and application to food industry residues. Bioproc Eng 23(6):613–620
29. Podschun R, Ullmann U (1998) Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11(4):589–603
30. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Ann Rev Biochem 71:635
31. Rim KB, Park JH, Oh MK, Lee JW (2012) Enhanced 2, 3-butanediol production in recombinant Klebsiella pneumoniae via overexpression of synthesis-related genes. J Microbiol Biotechnol 22(9):1258–1263
32. Ryan PA, Pancholi V, Fischetti VA (2001) Group A Streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors. Infect Immun 69(12):7402–7412
33. Sahly H, Podschun R, Oelschlaeger TA, Greiwe M, Parolis H, Hasty D, Kekow J, Ullmann U, Ofek I, Sela S (2000) Capsule impedes adhesion to and invasion of epithelial cells by Klebsiella pneumoniae. Infect Immun 68(12):6744–6749
34. Sawitzke JA, Thomason LC, Costantino N, Bubunenko M, Datta S, Court DL (2007) Recombineering: in vivo genetic engineering in E. coli, S. enterica, and beyond. Methods Enzymol 421:171–199
35. Schembri MA, Blom J, Krogfelt KA, Klemm P (2005) Capsule and fimbria interaction in Klebsiella pneumoniae. Infect Immun 73(8):4626–4633
36. Schild S, Lamprecht A-K, Fourestier C, Lauriano CM, Klose KE, Reidl J (2005) Characterizing lipopolysaccharide and core lipid A mutant O1 and O139 Vibrio cholerae strains for adherence properties on mucus-producing cell line HT29-Rev MTX and virulence in mice. Int J Med Microbiol 295(4):243–251
37. Shi L, Ardehali R, Caldwell KD, Valint P (2000) Mucin coating on polymeric material surfaces to suppress bacterial adhesion. Coll Surf B: Biointerfaces 17(4):229–239
38. Snyder J, Walker W (1987) Structure and function of intestinal mucin: developmental aspects. Int Arch Allergy Immunol 82(3–4):351–356
39. Spencer R (1996) Predominant pathogens found in the European prevalence of infection in intensive care study. Europ J Clin Microbiol Infect Dis 15(4):281–285
40. Strettoti CW, Ristuccia PA, Cunha BA (1984) Topics in clinical microbiology Klebsiella. Infect Cont 5(07):343–348
41. Struve C, Krogfelt KA (2003) Role of capsule in Klebsiella pneumoniae virulence: lack of correlation between in vitro and in vivo studies. FEMS Microbiol Lett 218(1):149–154
42. Tarkkanen A-M, Virkola R, Clegg S, Korhonen TK (1997) Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells. Infect Immun 65(4):1546–1549
43. Tarkkanen A, Allen BL, Williams P, Kauppi M, Haahtela K, Siitonen A, Orskov I, Orskov F, Clegg S, Korhonen T (1992) Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection. Infect Immun 60(3):1187–1192
44. Vishwanath S, Ramphal R (1984) Adherence of Pseudomonas aeruginosa to human tracheobronchial mucin. Infect Immun 45(1):197–202
45. Williams P, Tomas J (1990) The pathogenicity of Klebsiella pneumoniae. Rev Med Microbiol 1:196–204
46. Xiu Z-L, Zeng A-P (2008) Present state and perspective of downstream processing of biologically produced 1,3-propanediol and 2,3-butanediol. Appl Microbiol Biotechnol 78(6):917–926
47. Yinnon A, Butnaru A, Raveh D, Jerassy Z, Rudensky B (1996) Klebsiella bacteraemia: community versus nosocomial infection. QJM 89(12):933–942
48. Zeng A-P, Biebl H, Deckwer W-D (1990) Effect of pH and acetic acid on growth and 2,3-butanediol production of Enterobacter aerogenes in continuous culture. Appl Microbiol Biotechnol 33(5):485–489
49. Zeng A-P, Sabra W (2011) Microbial production of diols as platform chemicals: recent progresses. Curr Opin Biotechnol 22(6):749–757